← FDA Drug Approvals (Drugs@FDA)

SUSVIMO

BLA · Biologics License Application · Sponsor: GENENTECH INC · Approved 2021-10-22

Drug application

FDA Application #

BLA761197

Application type

Biologics License Application

Brand name

SUSVIMO

Generic name

RANIBIZUMAB

Active ingredients

RANIBIZUMAB

Dosage form

SOLUTION

Route

INJECTION

Marketing status

Prescription

Sponsor

GENENTECH INC

Manufacturer

Genentech, Inc.

First approval

2021-10-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown